PURPOSE: To develop a nano-structured porous polycaprolactone (NSP-PCL) scaffold and compare the articular cartilage repair potential with that of a commercially available collagen type I/III (Chondro-Gide) scaffold. METHODS: By combining rapid prototyping and thermally induced phase separation, the NSP-PCL scaffold was produced for matrix-assisted autologous chondrocyte implantation. Lyophilizing a water-dioxane-PCL solution created micro and nano-pores. In vitro: The scaffolds were seeded with rabbit chondrocytes and cultured in hypoxia for 6 days. qRT-PCR was performed using primers for sox9, aggrecan, collagen type 1 and 2. In vivo: 15 New Zealand White Rabbits received bilateral osteochondral defects in the femoral intercondylar grooves. Autologous chondrocytes were harvested 4 weeks prior to surgery. There were 3 treatment groups: (1) NSP-PCL scaffold without cells. (2) The Chondro-Gide scaffold with autologous chondrocytes and (3) NSP-PCL scaffold with autologous chondrocytes. Observation period was 13 weeks. Histological evaluation was made using the O'Driscoll score. RESULTS: In vitro: The expressions of sox9 and aggrecan were higher in the NSP-PCL scaffold, while expression of collagen 1 was lower compared to the Chondro-Gide scaffold. In vivo: Both NSP-PCL scaffolds with and without cells scored significantly higher than the Chondro-Gide scaffold when looking at the structural integrity and the surface regularity of the repair tissue. No differences were found between the NSP-PCL scaffold with and without cells. CONCLUSION: The NSP-PCL scaffold demonstrated higher in vitro expression of chondrogenic markers and had higher in vivo histological scores compared to the Chondro-Gide scaffold. The improved chondrocytic differentiation can potentially produce more hyaline cartilage during clinical cartilage repair. It appears to be a suitable cell-free implant for hyaline cartilage repair and could provide a less costly and more effective treatment option than the Chondro-Gide scaffold with cells.
PURPOSE: To develop a nano-structured porous polycaprolactone (NSP-PCL) scaffold and compare the articular cartilage repair potential with that of a commercially available collagen type I/III (Chondro-Gide) scaffold. METHODS: By combining rapid prototyping and thermally induced phase separation, the NSP-PCL scaffold was produced for matrix-assisted autologous chondrocyte implantation. Lyophilizing a water-dioxane-PCL solution created micro and nano-pores. In vitro: The scaffolds were seeded with rabbit chondrocytes and cultured in hypoxia for 6 days. qRT-PCR was performed using primers for sox9, aggrecan, collagen type 1 and 2. In vivo: 15 New Zealand White Rabbits received bilateral osteochondral defects in the femoral intercondylar grooves. Autologous chondrocytes were harvested 4 weeks prior to surgery. There were 3 treatment groups: (1) NSP-PCL scaffold without cells. (2) The Chondro-Gide scaffold with autologous chondrocytes and (3) NSP-PCL scaffold with autologous chondrocytes. Observation period was 13 weeks. Histological evaluation was made using the O'Driscoll score. RESULTS: In vitro: The expressions of sox9 and aggrecan were higher in the NSP-PCL scaffold, while expression of collagen 1 was lower compared to the Chondro-Gide scaffold. In vivo: Both NSP-PCL scaffolds with and without cells scored significantly higher than the Chondro-Gide scaffold when looking at the structural integrity and the surface regularity of the repair tissue. No differences were found between the NSP-PCL scaffold with and without cells. CONCLUSION: The NSP-PCL scaffold demonstrated higher in vitro expression of chondrogenic markers and had higher in vivo histological scores compared to the Chondro-Gide scaffold. The improved chondrocytic differentiation can potentially produce more hyaline cartilage during clinical cartilage repair. It appears to be a suitable cell-free implant for hyaline cartilage repair and could provide a less costly and more effective treatment option than the Chondro-Gide scaffold with cells.
Authors: Philipp Niemeyer; Jan M Pestka; Peter C Kreuz; Christoph Erggelet; Hagen Schmal; Norbert P Suedkamp; Matthias Steinwachs Journal: Am J Sports Med Date: 2008-09-18 Impact factor: 6.202
Authors: P Behrens; U Bosch; J Bruns; C Erggelet; S A Esenwein; C Gaissmaier; T Krackhardt; J Löhnert; S Marlovits; N M Meenen; J Mollenhauer; S Nehrer; F U Niethard; U Nöth; C Perka; W Richter; D Schäfer; U Schneider; M Steinwachs; K Weise Journal: Z Orthop Ihre Grenzgeb Date: 2004 Sep-Oct
Authors: Saey Tuan Barnabas Ho; Dietmar Werner Hutmacher; Andrew Krishna Ekaputra; Doshi Hitendra; James Hoi Hui Journal: Tissue Eng Part A Date: 2010-04 Impact factor: 3.845
Authors: Christopher X F Lam; Dietmar W Hutmacher; Jan-Thorsten Schantz; Maria Ann Woodruff; Swee Hin Teoh Journal: J Biomed Mater Res A Date: 2009-09-01 Impact factor: 4.396
Authors: Jonas Jensen; David Christian Evar Kraft; Helle Lysdahl; Casper Bindzus Foldager; Muwan Chen; Asger Albæk Kristiansen; Jan Hendrik Duedal Rölfing; Cody Eric Bünger Journal: Tissue Eng Part A Date: 2014-11-11 Impact factor: 3.845
Authors: Casper Bindzus Foldager; Cody Bünger; Anna Bay Nielsen; Michael Ulrich-Vinther; Samir Munir; Hanne Everland; Martin Lind Journal: Int Orthop Date: 2012-01-20 Impact factor: 3.075
Authors: James M Friedman; Mackenzie L Sennett; Marcelo B Bonadio; Kerry O Orji; Alexander L Neuwirth; Niobra Keah; James L Carey; Franklin T Moutos; Bradley T Estes; Farshid Guilak; Henning Madry; Robert L Mauck; George R Dodge Journal: Cartilage Date: 2017-04-11 Impact factor: 4.634
Authors: E Kon; G Filardo; D Robinson; J A Eisman; A Levy; K Zaslav; J Shani; N Altschuler Journal: Knee Surg Sports Traumatol Arthrosc Date: 2013-03-12 Impact factor: 4.342
Authors: Karl F Schüttler; Hanno Schenker; Christina Theisen; Markus D Schofer; Alan Getgood; Philip P Roessler; Johannes Struewer; Marga B Rominger; Turgay Efe Journal: Knee Surg Sports Traumatol Arthrosc Date: 2013-11-07 Impact factor: 4.342
Authors: Qingqiang Yao; Bo Wei; Nancy Liu; Chenshuang Li; Yang Guo; Arya Nick Shamie; James Chen; Cheng Tang; Chengzhe Jin; Yan Xu; Xiuwu Bian; Xinli Zhang; Liming Wang Journal: Tissue Eng Part A Date: 2015-04 Impact factor: 3.845
Authors: Bo Wei; Chengzhe Jin; Yan Xu; Xiaotao Du; Chao Yan; Cheng Tang; Mujtaba Ansari; Liming Wang Journal: Tissue Eng Part A Date: 2014-06-20 Impact factor: 3.845